A team of researchers from the University of Tennessee Graduate School of Medicine has spent more than two decades investigating systemic amyloidosis, a rare and often fatal disorder with few treatments. Their work played an integral role in moving discoveries out of the lab and into clinical trials, helping launch a biopharmaceutical company focused on (read more)
Startups
UTRF Licensee Attralus Secures $25M in Investment
Professor Jonathan Wall and his team at the UT Graduate School of Medicine have spent more than two decades investigating systemic amyloidosis. Their work played an integral role in helping launch the biopharmaceutical company Attralus with technology licensed from UTRF. Today, Attralus announced that it has secured $25 million in investment financing to work on (read more)
Supporting the Entrepreneurial Community: UTRF Helps Launch Six Technology Startups in FY 2020
Entrepreneurship sits at the heart of innovation, often driving commercialization and economic development in the state. The University of Tennessee has a wealth of innovators across the UT System who are constantly contributing their passions and skills to bring new ideas, goods, and services to the market. Committed to supporting entrepreneurial activity in the region, (read more)